Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 24;14(1):14468.
doi: 10.1038/s41598-024-65262-3.

Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock

Affiliations

Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock

Georg Franz Lehner et al. Sci Rep. .

Abstract

Coagulopathy, microvascular alterations and concomitant organ dysfunctions are hallmarks of sepsis. Attempts to attenuate coagulation activation with an inhibitor of tissue factor (TF), i.e. tissue factor pathway inhibitor (TFPI), revealed no survival benefit in a heterogenous group of sepsis patients, but a potential survival benefit in patients with an international normalized ratio (INR) < 1.2. Since an increased TF/TFPI ratio determines the procoagulant activity specifically on microvascular endothelial cells in vitro, we investigated whether TF/TFPI ratio in blood is associated with INR alterations, organ dysfunctions, disseminated intravascular coagulation (DIC) and outcome in septic shock. Twenty-nine healthy controls (HC) and 89 patients with septic shock admitted to a tertiary ICU were analyzed. TF and TFPI in blood was analyzed and related to organ dysfunctions, DIC and mortality. Patients with septic shock had 1.6-fold higher levels of TF and 2.9-fold higher levels of TFPI than HC. TF/TFPI ratio was lower in septic shock compared to HC (0.003 (0.002-0.005) vs. 0.006 (0.005-0.008), p < 0.001). Non-survivors had higher TFPI levels compared to survivors (43038 (29354-54023) vs. 28041 (21675-46582) pg/ml, p = 0.011). High TFPI levels were associated with acute kidney injury, liver dysfunction, DIC and disease severity. There was a positive association between TF/TFPI ratio and troponin T (b = 0.531 (0.309-0.754), p < 0.001). A high TF/TFPI ratio is exclusively associated with myocardial injury but not with other organ dysfunctions. Systemic TFPI levels seem to reflect disease severity. These findings point towards a pathophysiologic role of TF/TFPI in sepsis-induced myocardial injury.

Keywords: Coagulation; Microvasculature; Sepsis; Septic shock; Tissue factor; Tissue factor pathway inhibitor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Levels and kinetics of TF (a), TFPI (b) and ratio of TF/TFPI (c) in healthy controls and in patients with septic shock stratified according to ICU survival from day one to five. Mann–Whitney-U-Test was used for comparison of parameters between healthy controls and patients with septic shock on day one.
Figure 2
Figure 2
TF/TFPI ratio stratified according to INR 1.2 on day one. Bars represent medians and 95% confidence intervals. Statistical significance was tested with Mann–Whitney U.

References

    1. Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dal Nogare A, et al. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit. Care Med. 2001;29(11):2081–2089. doi: 10.1097/00003246-200111000-00007. - DOI - PubMed
    1. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Coagulopathy of acute sepsis. Semin. Thromb. Hemost. 2015;41(6):650–658. doi: 10.1055/s-0035-1556730. - DOI - PubMed
    1. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit. Care Med. 1998;26(12):2005–2009. doi: 10.1097/00003246-199812000-00030. - DOI - PubMed
    1. Musgrave KM, Scott J, Sendama W, Gardner AI, Dewar F, Lake CJ, et al. Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis. Thromb. Res. 2023;228:10–20. doi: 10.1016/j.thromres.2023.05.018. - DOI - PubMed
    1. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb. Res. 2012;129(3):290–295. doi: 10.1016/j.thromres.2011.10.013. - DOI - PubMed